Abstract

Review Article

Laws of Pathophysiology of Migraine in the Third Millennium

Vinod Kumar Gupta*

Published: 20 March, 2024 | Volume 8 - Issue 1 | Pages: 024-032

Science is the art of systematic and reproducible measurements, ultimately leading to knowledge supported by a holistic logic. Besides serendipity, there are 6 ways in general to obtain knowledge: authoritarianism; mysticism; rationalism, empiricism; pragmatism; and scepticism. Over the last 100 years, a canonical mythology – cortical spreading depression (CSD) – has prevailed in migraine pathophysiology. Conversely, a well-defined adaptive/protective role has evolved for CSD in locusts, Drosophila, and mammals. Additionally, an elaborate but entirely symptomatic nosologic system has arbitrarily evolved in migraine / primary headache. While the so-called systematic but symptomatic classification system of migraine / primary headache keeps on advancing the data-bank exponentially, the cause-effect nexus continues to obscure the most important systematic and insightful components of the knowledge of primary headache. The first step in advancing the cause-effect mystery of migraine / primary headache is to create a conceptual, consistent, and important adaptive-pathogenetic divide in the massive and disparate data-linked pathophysiology of the disorder. Once certain definitive principles (not laboratory/neuroimaging / genetic/epidemiologic data) emerge in the science of migraine / primary headache, we become empowered to understand the complex but key phenotypic blueprint as well as the neuro-pathophysiology / neuropsychiatry of the entity, including the visual (nasal visual-field sparing digitally-displaceable and eyeball-movement-synchronous scintillating scotomata), the lateralizing fronto-temporal-nuchal headache exclusively involving the ophthalmic division of the trigeminal nerve, and the associated features such as ‘stress’, ‘post-stress’, ‘autonomic storm’, ‘protean’ and ‘spontaneous’ onset and offset, and headache-aborting nausea-vomiting. In this manner, we have also evolved principles to begin to understand the most complex female predominance of migraine patients in adults [F:M=3:1] as well as the decline of prevalence in migraine attacks following menopause and advancing age. The Laws of the Pathophysiology of Migraine encompass the invaluable neurological / neuro-ophthalmological shift in pathophysiology from the brain to the eye.

Read Full Article HTML DOI: 10.29328/journal.jnnd.1001094 Cite this Article Read Full Article PDF

Keywords:

Migraine; Cortical spreading depression; Scintillating Scotoma (SS); Trigeminal nerve; Ophthalmic division of the trigeminal nerve; Autonomic nervous system; Intraocular pressure; Migraine-glaucoma-nexus; Digital ocular massage

References

  1. Mathew AA, Panonnummal R. Cortical spreading depression: culprits and mechanisms. Exp Brain Res. 2022 Mar;240(3):733-749. doi: 10.1007/s00221-022-06307-9. Epub 2022 Jan 22. PMID: 35064796.
  2. Takizawa T, Ayata C, Chen SP. Therapeutic implications of cortical spreading depression models in migraine. Prog Brain Res. 2020;255:29-67. doi: 10.1016/bs.pbr.2020.05.009. Epub 2020 Jun 27. PMID: 33008510.
  3. Soldozy S, Sharifi KA, Desai B, Giraldo D, Yeghyayan M, Liu L, Norat P, Sokolowski JD, Yağmurlu K, Park MS, Tvrdik P, Kalani MYS. Cortical Spreading Depression in the Setting of Traumatic Brain Injury. World Neurosurg. 2020 Feb;134:50-57. doi: 10.1016/j.wneu.2019.10.048. Epub 2019 Oct 23. PMID: 31655239.
  4. Close LN, Eftekhari S, Wang M, Charles AC, Russo AF. Cortical spreading depression as a site of origin for migraine: Role of CGRP. Cephalalgia. 2019 Mar;39(3):428-434. doi: 10.1177/0333102418774299. Epub 2018 Apr 25. PMID: 29695168; PMCID: PMC7007998.
  5. Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol. 2019 Aug;18(8):795-804. doi: 10.1016/S1474-4422(19)30185-1. Epub 2019 May 31. PMID: 31160203; PMCID: PMC7164539.
  6. Hartings JA, Shuttleworth CW, Kirov SA, Ayata C, Hinzman JM, Foreman B, Andrew RD, Boutelle MG, Brennan KC, Carlson AP, Dahlem MA, Drenckhahn C, Dohmen C, Fabricius M, Farkas E, Feuerstein D, Graf R, Helbok R, Lauritzen M, Major S, Oliveira-Ferreira AI, Richter F, Rosenthal ES, Sakowitz OW, Sánchez-Porras R, Santos E, Schöll M, Strong AJ, Urbach A, Westover MB, Winkler MK, Witte OW, Woitzik J, Dreier JP. The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy. J Cereb Blood Flow Metab. 2017 May;37(5):1571-1594. doi: 10.1177/0271678X16654495. Epub 2016 Jan 1. PMID: 27328690; PMCID: PMC5435288.
  7. Robertson RM, MacMillan HA, Andersen MK. A cold and quiet brain: mechanisms of insect CNS arrest at low temperatures. Curr Opin Insect Sci. 2023 Aug;58:101055. doi: 10.1016/j.cois.2023.101055. Epub 2023 May 16. PMID: 37201631.
  8. Andersen MK, Jensen NJS, Robertson RM, Overgaard J. Central nervous system shutdown underlies acute cold tolerance in tropical and temperate Drosophila J Exp Biol. 2018 Jun 15;221(Pt 12):jeb179598. doi: 10.1242/jeb.179598. PMID: 29739833.
  9. Robertson RM, Spong KE, Srithiphaphirom P. Chill coma in the locust, Locusta migratoria, is initiated by spreading depolarization in the central nervous system. Sci Rep. 2017 Aug 31;7(1):10297. doi: 10.1038/s41598-017-10586-6. PMID: 28860653; PMCID: PMC5579280.
  10. Rodgers CI, Armstrong GA, Robertson RM. Coma in response to environmental stress in the locust: a model for cortical spreading depression. J Insect Physiol. 2010 Aug;56(8):980-90. doi: 10.1016/j.jinsphys.2010.03.030. Epub 2010 Apr 7. PMID: 20361971.
  11. Armstrong GA, Rodgers CI, Money TG, Robertson RM. Suppression of spreading depression-like events in locusts by inhibition of the NO/cGMP/PKG pathway. J Neurosci. 2009 Jun 24;29(25):8225-35. doi: 10.1523/JNEUROSCI.1652-09.2009. PMID: 19553462; PMCID: PMC6666049.
  12. Rodgers CI, Armstrong GA, Shoemaker KL, LaBrie JD, Moyes CD, Robertson RM. Stress preconditioning of spreading depression in the locust CNS. PLoS One. 2007 Dec 26;2(12):e1366. doi: 10.1371/journal.pone.0001366. PMID: 18159249; PMCID: PMC2137934.
  13. Drongitis D, Rainone S, Piscopo M, Viggiano E, Viggiano A, De Luca B, Fucci L, Donizetti A. Epigenetics and cortical spreading depression: changes of DNA methylation level at retrotransposon sequences. Mol Biol Rep. 2016 Aug;43(8):755-60. doi: 10.1007/s11033-016-4000-4. Epub 2016 May 12. PMID: 27169424.
  14. Gupta VK. CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev Neurother. 2009 Nov;9(11):1595-614. doi: 10.1586/ern.09.103. PMID: 19903020.
  15. Shen PJ, Gundlach AL. Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD): implications for SD- and NO-mediated neuroprotection. Exp Neurol. 1999 Dec;160(2):317-32. doi: 10.1006/exnr.1999.7218. PMID: 10619550.
  16. Yanamoto H, Xue JH, Miyamoto S, Nagata I, Nakano Y, Murao K, Kikuchi H. Spreading depression induces long-lasting brain protection against infarcted lesion development via BDNF gene-dependent mechanism. Brain Res. 2004 Sep 3;1019(1-2):178-88. doi: 10.1016/j.brainres.2004.05.105. PMID: 15306252.
  17. Kobayashi S, Harris VA, Welsh FA. Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J Cereb Blood Flow Metab. 1995 Sep;15(5):721-7. doi: 10.1038/jcbfm.1995.92. PMID: 7673367.
  18. Gupta VK. Bimatoprost ophthalmic solution (BOS) 0.3 mg w/v for 1 open trial of long-term preventive therapy of migraine in 3 patients with pathophysiologic shift from brain to eye. Journal of Neuroscience and Neurological Disorders. 2023; 7:2; 134-154.
  19. Gawde P, Shah H, Patel H, Bharathi KS, Patel N, Sethi Y, Kaka N. Revisiting Migraine: The Evolving Pathophysiology and the Expanding Management Armamentarium. Cureus. 2023 Feb 2;15(2):e34553. doi: 10.7759/cureus.34553. PMID: 36879707; PMCID: PMC9985459.
  20. Wang M, Tutt JO, Dorricott NO, Parker KL, Russo AF, Sowers LP. Involvement of the cerebellum in migraine. Front Syst Neurosci. 2022 Oct 13;16:984406. doi: 10.3389/fnsys.2022.984406. PMID: 36313527; PMCID: PMC9608746.
  21. Lin YK, Tsai CL, Lin GY, Chou CH, Yang FC. Pathophysiology of Chronic Migraine: Insights from Recent Neuroimaging Research. Curr Pain Headache Rep. 2022 Nov;26(11):843-854. doi: 10.1007/s11916-022-01087-x. Epub 2022 Oct 7. PMID: 36207509.
  22. Bolay H. Thalamocortical network interruption: A fresh view for migraine symptoms. Turk J Med Sci. 2020 Nov 3;50(SI-2):1651-1654. doi: 10.3906/sag-2005-21. PMID: 32421284; PMCID: PMC7672341.
  23. Kros L, Angueyra Aristizábal CA, Khodakhah K. Cerebellar involvement in migraine. Cephalalgia. 2018 Oct;38(11):1782-1791. doi: 10.1177/0333102417752120. Epub 2018 Jan 22. PMID: 29357683.
  24. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017 Apr;97(2):553-622. doi: 10.1152/physrev.00034.2015. PMID: 28179394; PMCID: PMC5539409.
  25. Pietrobon D, Moskowitz MA. Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat Rev Neurosci. 2014 Jun;15(6):379-93. doi: 10.1038/nrn3770. PMID: 24857965.
  26. Piper RD, Edvinsson L, Ekman R, Lambert GA. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Cephalalgia. 1993 Jun;13(3):180-3; discussion 149. doi: 10.1046/j.1468-2982.1993.1303180.x. PMID: 8395344.
  27. Gupta VK. Pathophysiology of migraine: an increasingly complex narrative to 2020. Future Neurology 2020; 14: 2. Published Online: 24 May 2019. https://doi.org/10.2217/fnl-2019-0003
  28. Welch KM. Migraine. A biobehavioral disorder. Arch Neurol. 1987 Mar;44(3):323-7. doi: 10.1001/archneur.1987.00520150063024. PMID: 3827684.
  29. Welch KM, D'Andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990 Nov;8(4):817-28. PMID: 1979655.
  30. Gupta VK. Migrainous scintillating scotoma and headache is ocular in origin: A new hypothesis. Med Hypotheses. 2006;66(3):454-60. doi: 10.1016/j.mehy.2005.11.010. Epub 2005 Dec 13. PMID: 16356654.
  31. Gupta VK. Does magnesium supplementation have any role in acute myocardial infarction? No. Cardiovasc Drugs Ther. 1996 Jul;10(3):303-5. doi: 10.1007/BF02627952. PMID: 8877071.
  32. Altura BT, Altura BM. The role of magnesium in etiology of strokes and cerebrovasospasm. Magnesium. 1982; 1: 277-291.
  33. Mathew AA, Panonnummal R. 'Magnesium'-the master cation-as a drug-possibilities and evidences. Biometals. 2021 Oct;34(5):955-986. doi: 10.1007/s10534-021-00328-7. Epub 2021 Jul 2. PMID: 34213669; PMCID: PMC8249833.
  34. Dominguez LJ, Veronese N, Barbagallo M. Magnesium and hypertension in old age. Nutrients. 2021; 13(1): 139. Doi: 10.3390/nu13010139
  35. Maguire ME, Cowan JA. Magnesium chemistry and biochemistry. Biometals. 2002 Sep;15(3):203-10. doi: 10.1023/a:1016058229972. PMID: 12206387.
  36. Gupta VK. Eclampsia in the 21st Century: Paradigm shift from empirical therapy with magnesium sulfate. Basic science synthesis vs. current WHO-recommended pharmacotherapeutic practice. Brain and Neurological Disorders. 2023; 6(2). DOI:10.31579/2692 9422/045.
  37. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012 Feb;5(Suppl 1):i3-i14. doi: 10.1093/ndtplus/sfr163. PMID: 26069819; PMCID: PMC4455825.
  38. Schytz HW, Amin FM, Jensen RH, Carlsen L, Maarbjerg S, Lund N, Aegidius K, Thomsen LL, Bach FW, Beier D, Johansen H, Hansen JM, Kasch H, Munksgaard SB, Poulsen L, Sørensen PS, Schmidt-Hansen PT, Cvetkovic VV, Ashina M, Bendtsen L. Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020. J Headache Pain. 2021 Apr 8;22(1):22. doi: 10.1186/s10194-021-01228-4. PMID: 33832438; PMCID: PMC8034101.
  39. Gupta VK. Antimigraine action of nicotine: theoretical basis and potential clinical application. Eur J Emerg Med. 2007; 14(4): 243-244.
  40. Gupta VK. Once-weekly nocturnal ocular choroidal vascular decongestion by topical long-acting timolol solution applied to headache-ipsilateral eye to prevent weekend-migraine attacks: Smartphone-app assisted case report of 2 patients for 3-years and a brief mechanistic review. Neuroscience and Neurological Surgery. 2021; 9(1). DOI:10.31579/2578-8868/179.
  41. Karsan N, Bose RP, O'Daly O, Zelaya F, Goadsby PJ. Regional cerebral perfusion during the premonitory phase of triggered migraine: A double-blind randomized placebo-controlled functional imaging study using pseudo-continuous arterial spin labeling. Headache. 2023 Jun;63(6):771-787. doi: 10.1111/head.14538. Erratum in: Headache. 2023 Sep;63(8):1199. PMID: 37337681.
  42. Karsan N, Goadsby PJ. Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review. J Headache Pain. 2023 Aug 11;24(1):106. doi: 10.1186/s10194-023-01617-x. PMID: 37563570; PMCID: PMC10416375.
  43. Alpay B, Cimen B, Akaydin E, Bolay H, Sara Y. Levcromakalim provokes an acute rapid-onset migraine-like phenotype without inducing cortical spreading depolarization. J Headache Pain. 2023 Jul 24;24(1):93. doi: 10.1186/s10194-023-01627-9. PMID: 37488480; PMCID: PMC10367339.
  44. Wu S, Ren X, Zhu C, Wang W, Zhang K, Li Z, Liu X, Wang Y. A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine. J Headache Pain. 2022 Sep 30;23(1):128. doi: 10.1186/s10194-022-01496-8. PMID: 36180824; PMCID: PMC9524028.
  45. He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, Qin G, Chen L, Zhou J. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation. 2019 Apr 10;16(1):78. doi: 10.1186/s12974-019-1459-7. PMID: 30971286; PMCID: PMC6456991.
  46. Schankin CJ, Maniyar FH, Seo Y, Kori S, Eller M, Chou DE, Blecha J, Murphy ST, Hawkins RA, Sprenger T, VanBrocklin HF, Goadsby PJ. Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for 11 C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain. 2016l; 139(7): 1994–2001. Doi: 10.1093/brain/aww096. PMCID: PMC4939703. PMID: 27234268.
  47. Dreier JP. Is the blood-brain barrier differentially affected by different variants of migraine? Brain. 2016 Jul;139(Pt 7):1872-4. doi: 10.1093/brain/aww112. PMID: 27343220.
  48. Yildiz MB, Yildiz E, Balci S, Hasirci Bayir BR, Çetinkaya Y. Effect of migraine attack on pupil size, accommodation and ocular aberrations. Eur J Ophthalmol. 2021 Nov;31(6):3450-3455. doi: 10.1177/1120672120975334. Epub 2020 Nov 27. PMID: 33246366.
  49. Eren OE, Ruscheweyh R, Schankin C, Schöberl F, Straube A. The cold pressor test in interictal migraine patients - different parasympathetic pupillary response indicates dysbalance of the cranial autonomic nervous system. BMC Neurol. 2018 Apr 16;18(1):41. doi: 10.1186/s12883-018-1043-2. PMID: 29661162; PMCID: PMC5901875.
  50. Blitshteyn S. Dysautonomia, hypermobility spectrum disorders and mast cell activation syndrome as migraine comorbidities. Curr Neurol Neurosci Rep. 2023 Nov;23(11):769-776.Doi: 10.1007/s11910-023-01307-w. Epub 2023 Oct 17.
  51. Tiwari A, Maurya PK, Qavi A, Kulshreshtha D, Thacker AK, Singh AK. Cranial Autonomic Symptoms in Migraine: An Observational Study. Ann Indian Acad Neurol. 2022 Jul-Aug;25(4):654-659. doi: 10.4103/aian.aian_948_21. Epub 2022 May 12. PMID: 36211151; PMCID: PMC9540922.
  52. Yoshida S, Tanaka H, Mizutani M, Nakao R, Okamoto N, Kajiura M, Kanbara Y, Tamai H. Autonomic nervous system function in adolescent migraineurs. Pediatr Int. 2017 Sep;59(9):991-995. doi: 10.1111/ped.13342. PMID: 28612516.
  53. Gupta VK. Nitric oxide and migraine: Another systemic influence postulated to explain a lateralizing disorder. Eur J Neurol. 1996; 3(2):172-173. 1111/j.1468-1331.1996.tb00215.x.
  54. Chrousos GP, Gold PW. Introduction. In: Eds: Chrousos GP, McCarty R, Pacák K, Cizza G, Sternberg E, Gold PW, Kvetňanský R. Stress. Basic Mechanisms and Clinical Implications. ANN NY ACAD SCI. 1995; 771:xv-xviii.
  55. Gupta VK. Self-ocular compression maneuver immediately relieves migraine headache attacks: Case report of managing 100 attacks over 9 years and a mechanistic review. Acta Scientific Neurology. 2021a; 4.8: 72-77.
  56. Frazier R, Li BUK, Venkatesan T. Diagnosis and Management of Cyclic Vomiting Syndrome: A Critical Review. Am J Gastroenterol. 2023 Jul 1;118(7):1157-1167. doi: 10.14309/ajg.0000000000002216. Epub 2023 Feb 15. PMID: 36791365.                                
  57. Pinkhasov A, Xiong G, Bourgeois JA, Heinrich TW, Huang H, Coriolan S, Annamalai A, Mangal JP, Frankel S, Lang M, Raj YP, Dandois M, Barth K, Stewart AL, Rado J, Pesek J, Sanders A, Spearman-McCarthy EV, Gagliardi J, Fiedorowicz JG. Management of SIADH-related hyponatremia due to psychotropic medications - An expert consensus from the Association of Medicine and Psychiatry. J Psychosom Res. 2021 Dec;151:110654. doi: 10.1016/j.jpsychores.2021.110654. Epub 2021 Oct 28. PMID: 34739943; PMCID: PMC10911096.
  58. Venkatesan T, Levinthal DJ, Tarbell SE, Jaradeh SS, Hasler WL, Issenman RM, Adams KA, Sarosiek I, Stave CD, Sharaf RN, Sultan S, Li BUK. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil. 2019 Jun;31 Suppl 2(Suppl 2):e13604. doi: 10.1111/nmo.13604. PMID: 31241819; PMCID: PMC6899751.
  59. Boulet NP, Cloutier CJ, Ossenkopp KP, Kavaliers M. Oxytocin, social factors, and the expression of conditioned disgust (anticipatory nausea) in male rats. Behav Pharmacol. 2016 Dec;27(8):718-725. doi: 10.1097/FBP.0000000000000271. PMID: 27740965.
  60. Gupta V. Constipation-related migraine is linked to the effect pf the Valsalva maneuver on the eye: A case report and a mechanistic review. WebmedCentral NEUROLOGY 2010;1(12):WMC001433.
  61. Gupta VK. A hypothesis for the migraine headache syndrome. In: SPIRIT OF ENTERPRISE. THE 1990 ROLEX AWARDS. Section 1 - Applied Sciences and Invention. Buri International, Bern, Switzerland. ISBN 3 7169 2103 3. 1990; 155.
  62. Peatfield RC, Rose FC. Migrainous visual symptoms in a woman without eyes. Arch Neurol. 1981 Jul;38(7):466. doi: 10.1001/archneur.1981.00510070100024. PMID: 7247775.
  63. Nicolodi M, Frezzotti R, Diadori A, Nuti A, Sicuteri F. Phantom eye: features and prevalence. The predisposing role of headache. Cephalalgia. 1997 Jun;17(4):501-4. doi: 10.1046/j.1468-2982.1997.1704501.x. PMID: 9209770.
  64. Sörös P, Vo O, Husstedt IW, Evers S, Gerding H. Phantom eye syndrome: Its prevalence, phenomenology, and putative mechanisms. Neurology. 2003 May 13;60(9):1542-3. doi: 10.1212/01.wnl.0000059547.68899.f5. PMID: 12743251.
  65. Noseda R, Kainz V, Jakubowski M, Gooley JJ, Saper CB, Digre K, Burstein R. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010 Feb;13(2):239-45. doi: 10.1038/nn.2475. Epub 2010 Jan 10. PMID: 20062053; PMCID: PMC2818758.
  66. Silva GC, Góes CP, Vincent MB. Aura-like features and photophobia in sightless migraine patients. Arq Neuropsiquiatr. 2014 Dec;72(12):949-53. doi: 10.1590/0004-282X20140200. PMID: 25517643.
  67. Hupp SL, Kline LB, Corbett JJ. Visual disturbances of migraine. Surv Ophthalmol. 1989 Jan-Feb;33(4):221-36. doi: 10.1016/0039-6257(82)90149-7. PMID: 2652358.
  68. Blackmore NPI, Gleaves DH. Self-induced vomiting after drinking alcohol. Int J Ment Health Addiction. 2013; 11: 453–457. https://doi.org/10.1007/s11469-013-9430-9
  69. Łangowska-Grodzka B, Grodzka O, Czarnecki D, Domitrz I. Is there a correlation between migraine and eating disorders? A systematic literature review. Neurol Neurochir Pol. 2023;57(6):457-464. doi: 10.5603/pjnns.97307. Epub 2023 Dec 1. PMID: 38037683.
  70. Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, Hubalek IA, Marchenko Y, Overeem LH, Piroso S, Tkachev A, Martelletti P, Sacco S; European Headache Federation School of Advanced Studies (EHF-SAS). Migraine and sleep disorders: a systematic review. J Headache Pain. 2020 Oct 27;21(1):126. doi: 10.1186/s10194-020-01192-5. PMID: 33109076; PMCID: PMC7590682.
  71. Vgontzas A, Pavlović JM. Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms. Headache. 2018 Jul;58(7):1030-1039. doi: 10.1111/head.13358. Epub 2018 Aug 8. PMID: 30091160; PMCID: PMC6527324.
  72. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005 Jul-Aug;45(7):904-10. doi: 10.1111/j.1526-4610.2005.05159.x. PMID: 15985108.
  73. Sahota PK, Dexter JD. Sleep and headache syndromes: a clinical review. Headache. 1990 Jan;30(2):80-4. doi: 10.1111/j.1526-4610.1990.hed3002080.x. PMID: 2406223.
  74. Blau JN. Resolution of migraine attacks: sleep and the recovery phase. J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):223-6. doi: 10.1136/jnnp.45.3.223. PMID: 7086442; PMCID: PMC491341.
  75. Nadal M. Secretory rhythm of vasopressin in healthy subjects with inversed sleep--wake cycle: evidence for the existence of an intrinsic regulation. Eur J Endocrinol. 1996 Feb;134(2):174-6. doi: 10.1530/eje.0.1340174. PMID: 8630515.
  76. Valiquette G. The neurohypophysis. Neurol Clin. 1987 May;5(2):291-331, vi-vii. PMID: 11681404.
  77. Born J, Kellner C, Uthgenannt D, Kern W, Fehm HL. Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am J Physiol. 1992 Mar;262(3 Pt 1):E295-300. doi: 10.1152/ajpendo.1992.262.3.E295. PMID: 1550223.
  78. Sasone L, Milani F, Fabrizi R, Belli M, Cristina M, Zagà V. Nicotine: From discovery to biological effects. Int J Mol Sci. 2023;24(19):14570. Doi: 10.3390/ijms241914570.
  79. Custodio L, Malone S, Bardo MT, Turner JR. Nicotine and opioid co-dependence: Findings from bench research to clinical trials. Neurosci Biobehav Rev. 2022 Mar;134:104507. doi: 10.1016/j.neubiorev.2021.12.030. Epub 2021 Dec 27. PMID: 34968525.
  80. Stalnikowicz R. Nicotine gum withdrawal and migraine headaches. Eur J Emerg Med. 2006 Aug;13(4):247-8. doi: 10.1097/01.mej.0000209066.13697.15. PMID: 16816594.
  81. Varangot-Reille C, Suso-Martí L, Romero-Palau M, Suárez-Pastor P, Cuenca-Martínez F. Effects of Different Therapeutic Exercise Modalities on Migraine or Tension-Type Headache: A Systematic Review and Meta-Analysis with a Replicability Analysis. J Pain. 2022 Jul;23(7):1099-1122. doi: 10.1016/j.jpain.2021.12.003. Epub 2021 Dec 18. PMID: 34929374.
  82. Amin FM, Aristeidou S, Baraldi C, Czapinska-Ciepiela EK, Ariadni DD, Di Lenola D, Fenech C, Kampouris K, Karagiorgis G, Braschinsky M, Linde M; European Headache Federation School of Advanced Studies (EHF-SAS). The association between migraine and physical exercise. J Headache Pain. 2018 Sep 10;19(1):83. doi: 10.1186/s10194-018-0902-y. PMID: 30203180; PMCID: PMC6134860.
  83. Lippi G, Mattiuzzi C, Sanchis-Gomar F. Physical exercise and migraine: for or against? Ann Transl Med. 2018 May;6(10):181. doi: 10.21037/atm.2018.04.15. PMID: 29951503; PMCID: PMC5994516.
  84. Hew-Butler T. Arginine vasopressin, fluid balance and exercise: is exercise-associated hyponatraemia a disorder of arginine vasopressin secretion? Sports Med. 2010 Jun 1;40(6):459-79. doi: 10.2165/11532070-000000000-00000. PMID: 20524712.
  85. Allais G, Chiarle G, Sinigaglia S, Mana O, Benedetto C. Migraine during pregnancy and in the puerperium. Neurol Sci. 2019 May;40(Suppl 1):81-91. doi: 10.1007/s10072-019-03792-9. PMID: 30880362.
  86. Szewczyk AK, Ulutas S, Aktürk T, Al-Hassany L, Börner C, Cernigliaro F, Kodounis M, Lo Cascio S, Mikolajek D, Onan D, Ragaglini C, Ratti S, Rivera-Mancilla E, Tsanoula S, Villino R, Messlinger K, Maassen Van Den Brink A, de Vries T; European Headache Federation School of Advanced Studies (EHF-SAS). Prolactin and oxytocin: potential targets for migraine treatment. J Headache Pain. 2023 Mar 27;24(1):31. doi: 10.1186/s10194-023-01557-6. PMID: 36967387; PMCID: PMC10041814.
  87. Stachenfeld NS, DiPietro L, Palter SF, Nadel ER. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol. 1998 Jan;274(1):R187-95. doi: 10.1152/ajpregu.1998.274.1.R187. PMID: 9458917.
  88. Zheng H, Lim JY, Kim Y, Jung ST, Hwang SW. The role of oxytocin, vasopressin, and their receptors at nociceptors in peripheral pain modulation. Front Neuroendocrinol. 2021 Oct;63:100942. doi: 10.1016/j.yfrne.2021.100942. Epub 2021 Aug 23. PMID: 34437871.
  89. Yoshizawa T. New experimental model system to study central regulation of intraocular pressure. Jpn J Ophthalmol. 1993;37(1):9-15. PMID: 8320871.
  90. Johnson AG, Crawford GA, Kelly D, Nguyen TV, Gyory AZ. Arginine vasopressin and osmolality in the elderly. J Am Geriatr Soc. 1994 Apr;42(4):399-404. doi: 10.1111/j.1532-5415.1994.tb07488.x. PMID: 8144825.
  91. Kim J, Aschard H, Kang JH, Lentjes MAH, Do R, Wiggs JL, Khawaja AP, Pasquale LR; Modifiable Risk Factors for Glaucoma Collaboration. Intraocular Pressure, Glaucoma, and Dietary Caffeine Consumption: A Gene-Diet Interaction Study from the UK Biobank. Ophthalmology. 2021 Jun;128(6):866-876. doi: 10.1016/j.ophtha.2020.12.009. Epub 2020 Dec 14. PMID: 33333105; PMCID: PMC8154631.
  92. Nicholson SA. Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat. J Endocrinol. 1989 Aug;122(2):535-43. doi: 10.1677/joe.0.1220535. PMID: 2549162.
  93. Marley A, Bakali M, Simpson C. Effect of a moderate alcohol dose on physiological responses during rest and prolonged cycling. Alcohol Alcohol. 2024 Jan 17;59(2):agad079. doi: 10.1093/alcalc/agad079. PMID: 37981293; PMCID: PMC10794168.
  94. Vera J, Jiménez R, Redondo B, Torrejón A, Koulieris GA, De Moraes CG, García-Ramos A. Investigating the Immediate and Cumulative Effects of Isometric Squat Exercise for Different Weight Loads on Intraocular Pressure: A Pilot Study. Sports Health. 2019 May/Jun;11(3):247-253. doi: 10.1177/1941738119834985. Epub 2019 Apr 15. PMID: 30986115; PMCID: PMC6537322.
  95. Gupta VK. Systemic hypertension, headache, and ocular hemodynamics: a new hypothesis. MedGenMed. 2006 Sep 12;8(3):63. PMID: 17406187; PMCID: PMC1781314.
  96. Gupta VK. Patent foramen ovale closure and migraine: science and sensibility. Expert Rev Neurother. 2010 Sep;10(9):1409-22. doi: 10.1586/ern.10.125. PMID: 20819012.
  97. Akerman S, Romero-Reyes M, Karsan N, Bose P, Hoffmann JR, Holland PR, Goadsby PJ. Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives. Pain. 2021 May 1;162(5):1567-1577. doi: 10.1097/j.pain.0000000000002142. PMID: 33181579.
  98. Gupta VK. Magnesium therapy for migraine: do we need more trials or more reflection? Headache. 2004 May;44(5):445-6. doi: 10.1111/j.1526-4610.2004.04098_2.x. PMID: 15147256.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?